From the preceding discussion, we speculated that both genes are diagnostic biomarkers for childhood ITP, and the increasing IFNS-AS1 and GAS5 expressions in childhood ITP patients may participate in the progress of the disease, especially its higher levels were significantly associated with persistent and chronic ITP patients than newly diagnosed patients. The gene discussed is GAS5; the disease is autoimmune thrombocytopenic purpura.